Digoxin for neoplastic cells, circulating

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Apr 2019: Trial registered, NCT03928210
  2. 8 Jul 2020: Trial started, NCT03928210

The trials

NCT03928210: Digoxin Induced Dissolution of CTC Clusters

State
Completed
Phase
Early Phase 1
People
58 taking part
Started
8 Jul 2020
Primary completion
1 Dec 2023
Arms
Digoxin
Results
None posted
  1. 26 Apr 2019: Trial registered
  2. 8 Jul 2020: Trial started
  3. 1 Dec 2023: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as Lanoxin.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.